Introduction In the global monkeypox outbreak primary preventive vaccination is offered to
people at higher risk for infection. We study vaccine acceptance and its determinants, to …

Introduction In the 2022 multicountry mpox (formerly named monkeypox) outbreak, several
countries offered primary preventive vaccination (PPV) to people at higher risk for infection …

Objectives To assess knowledge and concern about monkeypox, acceptability of
behavioural changes to reduce transmission risk, and willingness to be vaccinated among …

The current monkeypox epidemic is most prevalent among men who have sex with men
(MSM). PrEP users and MSM with HIV (MSMHIV) are considered at highest risk of …

Background MSM individuals are at high risk of monkeypox infection, and judicious use of
vaccines can control the outbreak. Therefore, we conducted a national cross-sectional …

Background The May 2022 global outbreak of monkeypox (MPX) poses a threat to the
health of men who have sex with men. However, there is limited data on the willingness of …

Abstract Before 2022, monkeypox virus (Mpox) infection in humans was seldom reported
outside Africa. During the May 2022 outbreak, most cases were detected among men who …

Background: The public's attitude towards Mpox vaccination is a critical factor in the success
of immunisation programmes. Understanding the factors contributing to vaccine acceptance …

People with pre-exposure prophylaxis (PrEP) or living with HIV are a high-risk population for
monkeypox virus (MPXV) infection. It is important to achieve high MPXV vaccination …

Vaccination it is considered a vital strategy in order to mitigate monkeypox by protecting from
severe disease and helping in reduction of hospitalisations. In this sense, this study aims to …